HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment - Milde, Till; Lodrini, Marco; Korshunov, Andrey; Kool, Marcel; Pfister, Stefan; Kulozik, Andreas; Witt, Olaf; Deubzer, Hedwig (Journal of neuro-oncology, 2012)
Gesehen am 29.11.2018